Bowel bacteria, drugs targeting cancers’ metabolic weaknesses and DNA ‘signatures’ – the brightest new ideas in cancer research
What do you get when you combine scientists, a ‘Dragon’s Den’-style pitch, and £200,000 to fund cancer research?
Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why.
Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments.
Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance.
We investigate organoids, the latest way that scientists are growing cancer cells in the lab to help test hundreds of cancer drugs.
Advanced imaging technology is helping our scientists understand how key molecules fuel the growth of breast cancer cells.
Inherited gene faults are more common among men with advanced prostate cancer than in those with localised disease.
An analysis of the complete genetic code of hundreds of breast tumours could lead to more personalised care for patients.